›› 2018, Vol. 38 ›› Issue (6): 605-.doi: 10.3969/j.issn.1674-8115.2018.06.004
• Original article (Basic research) • Previous Articles Next Articles
DONG Ya, YANG Ruo-lin, SHEN Zheng-wu, LIU Jian-hua
Online:
Published:
Supported by:
Abstract: Objective · To discover lead compounds with 6,11-dihydro-5H-benzo[a]carbazole as core scaffold that can inhibit the proliferation of cervical cancer cells. Methods · A series of 6,11-dihydro-5H-benzo[a]carbazole derivatives and analogs were synthesized using Fischer indole synthesis method, and their anticancer activity against HeLa cells was tested in vitroCCK8 test. Results · 2-Methoxy-6,11-dihydro-5H-benzo[a]carbazole and 8-chloro-2methoxy- 6,11-dihydro-5H-benzo[a]carbazole could significantly inhibit the proliferation of HeLa cells with the half maximal inhibitory concentration (IC50)values of 9.61 μmol/L and 16.52 μmol/L, respectively. Conclusion · Two objective lead compounds were found. Among 6,11-dihydro-5H-benzo[a]carbazole derivatives, compounds with methoxy group at the C-2 position of the core scaffold show better activity against proliferation of cervical cancer cells.
Key words: 6,11-dihydro-5H-benzo[a]carbazole analogues, privileged structure, cervical cancer, lead compound
CLC Number:
R914.5
DONG Ya, YANG Ruo-lin, SHEN Zheng-wu, LIU Jian-hua. Discovery of lead compounds to inhibit proliferation of cervical cancer cells based on privileged structure of 6,11-dihydro-5H-benzo[a]carbazole[J]. , 2018, 38(6): 605-.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2018.06.004
https://xuebao.shsmu.edu.cn/EN/Y2018/V38/I6/605